Treating Concurrent Substance Use Among Adults (SAMHSA)

The guide presents three evidence-based practices that engage and improve outcomes for individuals with concurrent substance use and concurrent substance use disorders:

• FDA-approved pharmacotherapy together with counseling to treat two substance combinations: 1. alcohol and cocaine dependence and 2. cocaine and opioid dependence
• Contingency management together with FDA-approved pharmacotherapy and counseling to treat two substance combinations: 1. cocaine and opioid use and dependence and 2. cocaine dependence and alcohol and opioid use
• Twelve-step facilitation therapy together with FDA-approved pharmacotherapy and counseling to treat two substance combinations: 1. cocaine and opioid dependence and 2. opioid and other substance dependence

The guide provides considerations and strategies for clinicians and organizations implementing evidence-based practices. These approaches will assist clinicians, behavioral health organizations, primary care providers, insurers, and policy makers in understanding, selecting, and implementing evidence-based interventions that support adults with concurrent substance use and/or concurrent substance use disorders

Resources Provided:

• Treating Concurrent Substance Use Among Adults (SAMHSA)

Date added: November 7, 2022